Page 225 - Pharmaceutics IV (02-06-01305)
P. 225

30/03/2024

    Drug development cost

    $300-600 mio                   New Chemical Entity

    $50 mio  Nasal Drug Delivery

             Dr ALyaa Ramadan, AU  25

25

    Limitations

     Once administered, rapid removal of the

         therapeutic agent from the site of absorption is
         difficult

     Pathologic conditions such as cold or allergies

         may alter significantly the nasal bioavailability

             Dr ALyaa Ramadan, AU  26

26

                                                            13
   220   221   222   223   224   225   226   227   228   229   230